{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:00:36Z","timestamp":1792083636633,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ER1504"],"award-info":[{"award-number":["01ER1504"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1512D"],"award-info":[{"award-number":["01GM1512D"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Deutsche Kinder-Rheumastiftung","award":["not applicable"],"award-info":[{"award-number":["not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0224-2","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T07:21:04Z","timestamp":1516605664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany"],"prefix":"10.1186","volume":"16","author":[{"name":"PRO-KIND SJIA project collaborators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claas H.","family":"Hinze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Holzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Lainka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes-Peter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Speth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann","family":"Kallinich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette F.","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Winowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Foeldvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Hospach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Iko","family":"Huppertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"M\u00f6nkem\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Neudorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Wei\u00dfbarth-Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Wittkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Foell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"key":"224_CR1","doi-asserted-by":"crossref","unstructured":"Mellins ED, Macaubas C, Grom AA: Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nature reviews Rheumatology. 2011;7(7):416-426.","DOI":"10.1038\/nrrheum.2011.68"},{"issue":"1","key":"224_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM196701052760102","volume":"276","author":"JJ Calabro","year":"1967","unstructured":"Calabro JJ, Marchesano JM. Fever associated with juvenile rheumatoid arthritis. N Engl J Med. 1967;276(1):11\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"224_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/art.21774","volume":"54","author":"D Singh-Grewal","year":"2006","unstructured":"Singh-Grewal D, Schneider R, Bayer N, Feldman BM. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum. 2006;54(5):1595\u2013601.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"224_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/art.38615","volume":"66","author":"PA Nigrovic","year":"2014","unstructured":"Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol. 2014;66(6):1405\u201313.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"224_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.30128","volume":"63","author":"PA Nigrovic","year":"2011","unstructured":"Nigrovic PA, Mannion M, Prince FH, Zeft A, Rabinovich CE, van Rossum MA, Cortis E, Pardeo M, Miettunen PM, Janow G, et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum. 2011;63(2):545\u201355.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"224_CR6","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/art.38296","volume":"66","author":"SJ Vastert","year":"2014","unstructured":"Vastert SJ, de Jager W, Noordman BJ, Holzinger D, Kuis W, Prakken BJ, Wulffraat NM. Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. Arthritis Rheumatol. 2014;66(4):1034\u201343.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"224_CR7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1136\/annrheumdis-2012-201388","volume":"71","author":"A Martini","year":"2012","unstructured":"Martini A. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis. 2012;71(9):1437\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"224_CR8","first-page":"322","volume":"28","author":"B Fautrel","year":"2001","unstructured":"Fautrel B, Le Moel G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S, Koeger AC, Meyer O, Guillevin L, Piette JC, et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol. 2001;28(2):322\u20139.","journal-title":"J Rheumatol"},{"issue":"3","key":"224_CR9","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19(3):424\u201330.","journal-title":"J Rheumatol"},{"issue":"1","key":"224_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3109\/03009749609082663","volume":"25","author":"P Picco","year":"1996","unstructured":"Picco P, Gattorno M, Buoncompagni A, Pistoia V, Borrone C. 6-methylprednisolone 'mini-pulses': a new modality of glucocorticoid treatment in systemic onset juvenile chronic arthritis. Scand J Rheumatol. 1996;25(1):24\u20137.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"224_CR11","first-page":"281","volume":"61","author":"BM Ansell","year":"1968","unstructured":"Ansell BM. Problems of corticosteroid therapy in the young. Proc R Soc Med. 1968;61(3):281\u20132.","journal-title":"Proc R Soc Med"},{"issue":"25","key":"224_CR12","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F De Benedetti","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367(25):2385\u201395.","journal-title":"N Engl J Med"},{"issue":"5","key":"224_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/ard.2010.134254","volume":"70","author":"P Quartier","year":"2011","unstructured":"Quartier P, Allantaz F, Cimaz R, Pillet P, Messiaen C, Bardin C, Bossuyt X, Boutten A, Bienvenu J, Duquesne A, et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis. 2011;70(5):747\u201354.","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"224_CR14","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367(25):2396\u2013406.","journal-title":"N Engl J Med"},{"issue":"4","key":"224_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465\u201382.","journal-title":"Arthritis Care Res"},{"issue":"7","key":"224_CR16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","volume":"64","author":"EM DeWitt","year":"2012","unstructured":"DeWitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, Schneider R, Stoll ML, Angeles-Han S, Milojevic D, et al. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res. 2012;64(7):1001\u201310.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"224_CR17","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.38092","volume":"65","author":"S Ringold","year":"2013","unstructured":"Ringold S, Weiss PF, Beukelman T, EM DW, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum. 2013;65(10):2499\u2013512.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"224_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00442095","volume":"135","author":"E Stoeber","year":"1981","unstructured":"Stoeber E. Prognosis in juvenile chronic arthritis. Follow-up of 433 chronic rheumatic children. Eur J Pediatr. 1981;135(3):225\u20138.","journal-title":"Eur J Pediatr"},{"issue":"11","key":"224_CR19","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C","volume":"43","author":"LR Spiegel","year":"2000","unstructured":"Spiegel LR, Schneider R, Lang BA, Birdi N, Silverman ED, Laxer RM, Stephens D, Feldman BM. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum. 2000;43(11):2402\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"224_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.clim.2011.10.003","volume":"142","author":"G Dueckers","year":"2012","unstructured":"Dueckers G, Guellac N, Arbogast M, Dannecker G, Foeldvari I, Frosch M, Ganser G, Heiligenhaus A, Horneff G, Illhardt A, et al. Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis. Clin Immunol. 2012;142(2):176\u201393.","journal-title":"Clin Immunol"},{"issue":"12","key":"224_CR21","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/art.39796","volume":"68","author":"J Klotsche","year":"2016","unstructured":"Klotsche J, Raab A, Niewerth M, Sengler C, Ganser G, Kallinich T, Niehues T, Hufnagel M, Thon A, Hospach T, et al. Outcome and trends in treatment of systemic juvenile idiopathic arthritis in the German National Pediatric Rheumatologic Database, 2000-2013. Arthritis Rheumatol. 2016;68(12):3023\u201334.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"224_CR22","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1136\/annrheumdis-2014-205372","volume":"74","author":"J Guzman","year":"2015","unstructured":"Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Boire G, Scuccimarri R, Berard R, Tse SM, Morishita K, et al. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-out cohort. Ann Rheum Dis. 2015;74(10):1854\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"224_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"224_CR24","first-page":"290","volume":"11","author":"C Hinze","year":"2015","unstructured":"Hinze C, Gohar F, Foell D. Management of juvenile idiopathic arthritis: hitting the target. Nature reviews. Rheumatology. 2015;11(5):290\u2013300.","journal-title":"Rheumatology"},{"issue":"4 Suppl 73","key":"224_CR25","first-page":"S157","volume":"30","author":"A Consolaro","year":"2012","unstructured":"Consolaro A, Negro G, Lanni S, Solari N, Martini A, Ravelli A. Toward a treat-to-target approach in the management of juvenile idiopathic arthritis. Clin Exp Rheumatol. 2012;30(4 Suppl 73):S157\u201362.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"224_CR26","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2290\u20134.","journal-title":"J Rheumatol"},{"key":"224_CR27","unstructured":"Oxford Centre for Evidence-based Medicine \u2013 Levels of Evidence (March 2009) [ http:\/\/www.cebm.net\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/ ]."},{"issue":"6","key":"224_CR28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00296-010-1584-1","volume":"31","author":"D Suri","year":"2011","unstructured":"Suri D, Ahluwalia J, Sachdeva MU, Das R, Varma N, Singh S. Arthritic presentation of childhood malignancy: beware of normal blood counts. Rheumatol Int. 2011;31(6):827\u20139.","journal-title":"Rheumatol Int"},{"issue":"10","key":"224_CR29","first-page":"1665","volume":"66","author":"MS Tamashiro","year":"2011","unstructured":"Tamashiro MS, Aikawa NE, Campos LM, Cristofani LM, Odone-Filho V, Silva CA. Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset. Clinics. 2011;66(10):1665\u20139.","journal-title":"Clinics"},{"issue":"6","key":"224_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1053\/sarh.2000.5752","volume":"29","author":"S Trapani","year":"2000","unstructured":"Trapani S, Grisolia F, Simonini G, Calabri GB, Falcini F. Incidence of occult cancer in children presenting with musculoskeletal symptoms: a 10-year survey in a pediatric rheumatology unit. Semin Arthritis Rheum. 2000;29(6):348\u201359.","journal-title":"Semin Arthritis Rheum"},{"issue":"35","key":"224_CR31","first-page":"1613","volume":"146","author":"AH Koolman","year":"2002","unstructured":"Koolman AH, Kamphuis SS, Weggelaar NM, van den Bos C, Wulffraat NM, Revesz T. Children with fever peaks and bone and joint pain: systemic juvenile idiopathic arthritis or acute lymphoblastic leukemia after all? Ned Tijdschr Geneeskd. 2002;146(35):1613\u20136.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"224_CR32","unstructured":"Leitlinie der Gesellschaft f\u00fcr Kinder- und Jugendrheumatologie und der Deutschen Gesellschaft f\u00fcr Kinder- und Jugendmedizin: Fieber unklarer Genese [ http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/027-053.html ]."},{"issue":"5","key":"224_CR33","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/art.23437","volume":"58","author":"M Gattorno","year":"2008","unstructured":"Gattorno M, Piccini A, Lasiglie D, Tassi S, Brisca G, Carta S, Delfino L, Ferlito F, Pelagatti MA, Caroli F, et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2008;58(5):1505\u201315.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"224_CR34","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/art.34373","volume":"64","author":"A Consolaro","year":"2012","unstructured":"Consolaro A, Bracciolini G, Ruperto N, Pistorio A, Magni-Manzoni S, Malattia C, Pederzoli S, Davi S, Martini A, Ravelli A, et al. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Arthritis Rheum. 2012;64(7):2366\u201374.","journal-title":"Arthritis Rheum"},{"key":"224_CR35","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM et al: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31(2):390-392."},{"issue":"2","key":"224_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"EG Bywaters","year":"1971","unstructured":"Bywaters EG. Still's disease in the adult. Ann Rheum Dis. 1971;30(2):121\u201333.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"224_CR37","first-page":"343","volume":"35","author":"EM Behrens","year":"2008","unstructured":"Behrens EM, Beukelman T, Gallo L, Spangler J, Rosenkranz M, Arkachaisri T, Ayala R, Groh B, Finkel TH, Cron RQ. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania systemic onset juvenile arthritis registry (PASOJAR). J Rheumatol. 2008;35(2):343\u20138.","journal-title":"J Rheumatol"},{"key":"224_CR38","doi-asserted-by":"crossref","unstructured":"Put K, Vandenhaute J, Avau A, Van Nieuwenhuijze A, Brisse E, Dierckx T, Rutgeerts O, Garcia-Perez J, Toelen J, Waer M, et al. Inflammatory gene expression profile and defective IFN-gamma and granzyme K in natural killer cells of systemic juvenile idiopathic arthritis patients. Arthritis Rheumatol. 2017;69(1):213-224","DOI":"10.1002\/art.39933"},{"issue":"52","key":"224_CR39","doi-asserted-by":"publisher","first-page":"15970","DOI":"10.1073\/pnas.1520779112","volume":"112","author":"MJ Ombrello","year":"2015","unstructured":"Ombrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, Martini A, Gattorno M, Ozen S, Prahalad S, et al. HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci U S A. 2015;112(52):15970\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"224_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13075-016-1069-z","volume":"18","author":"F Gohar","year":"2016","unstructured":"Gohar F, Kessel C, Lavric M, Holzinger D, Foell D. Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks? Arthritis Res Ther. 2016;18:163.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"224_CR41","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/annrheumdis-2011-200598","volume":"71","author":"D Holzinger","year":"2012","unstructured":"Holzinger D, Frosch M, Kastrup A, Prince FH, Otten MH, Van Suijlekom-Smit LW, ten Cate R, Hoppenreijs EP, Hansmann S, Moncrieffe H, et al. The toll-like receptor 4 agonist MRP8\/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. Ann Rheum Dis. 2012;71(6):974\u201380.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"224_CR42","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1002\/art.24137","volume":"58","author":"H Wittkowski","year":"2008","unstructured":"Wittkowski H, Frosch M, Wulffraat N, Goldbach-Mansky R, Kallinich T, Kuemmerle-Deschner J, Fruhwald MC, Dassmann S, Pham TH, Roth J, et al. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum. 2008;58(12):3924\u201331.","journal-title":"Arthritis Rheum"},{"key":"224_CR43","unstructured":"Martini A. Oral presentation: toward a new classification of JIA. In: PRES annual meeting. Genoa, Italy: Paediatric Rheumatology European Society; 2016."},{"issue":"7","key":"224_CR44","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/acr.22583","volume":"67","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, Brunner HI, Ogawa R, Felson D, Ogdie A, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res. 2015;67(7):891\u20137.","journal-title":"Arthritis Care Res"},{"key":"224_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12969-015-0047-3","volume":"13","author":"N Nirmala","year":"2015","unstructured":"Nirmala N, Brachat A, Feist E, Blank N, Specker C, Witt M, Zernicke J, Martini A, Junge G. Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity. Pediatr Rheumatol Online J. 2015;13:50.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"224_CR46","doi-asserted-by":"publisher","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","volume":"146","author":"YP Goekoop-Ruiterman","year":"2007","unstructured":"Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Peeters AJ, de Jonge-Bok JM, Mallee C, et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med. 2007;146(6):406\u201315.","journal-title":"Ann Intern Med"},{"issue":"9430","key":"224_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","volume":"364","author":"C Grigor","year":"2004","unstructured":"Grigor C, Capell H, Stirling A, AD MM, Lock P, Vallance R, Kincaid W, Porter D. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet. 2004;364(9430):263\u20139.","journal-title":"Lancet"},{"key":"224_CR48","doi-asserted-by":"crossref","unstructured":"Sengler C, Klotsche J, Niewerth M, Liedmann I, Foll D, Heiligenhaus A, Ganser G, Horneff G, Haas JP, Minden K: The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort. RMD Open 2015, 1(1):e000074.","DOI":"10.1136\/rmdopen-2015-000074"},{"issue":"5","key":"224_CR49","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/BOR.0b013e32830c690f","volume":"20","author":"MH Passo","year":"2008","unstructured":"Passo MH, Taylor J. Quality improvement in pediatric rheumatology: what do we need to do? Curr Opin Rheumatol. 2008;20(5):625\u201330.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"224_CR50","first-page":"57","volume":"10","author":"DW EM","year":"2014","unstructured":"EM DW, Brunner HI. The landscape of comparative effectiveness research in rheumatology. Nature reviews. Rheumatology. 2014;10(1):57\u201362.","journal-title":"Rheumatology"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0224-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T13:21:13Z","timestamp":1719753673000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0224-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0224-2","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,22]]},"assertion":[{"value":"8 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The AID-Net was approved by the ethics committee of the physicians\u2019 chamber Westfalen-Lippe and the University of M\u00fcnster. Both ICON-JIA and the national pediatric rheumatology database were approved by the ethics committee of the Charit\u00e9 in Berlin.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Hinze has received consulting fees, speaking fees, and\/or honoraria from Novartis (less than $10,000 each). Dr. Holzinger has received consulting fees, speaking fees, and\/or honoraria from Novartis and Pfizer (less than $10,000 each) and research support from Pfizer. Dr. Lainka has received consulting fees, speaking fees, and\/or honoraria from Novartis (less than $10,000 each) and research support from Sobi. Dr. Haas has received research support from Novartis and Pfizer. Dr. Kallinich has received consulting fees, speaking fees, and\/or honoraria from Bristol-Myers-Squibb, CSL, Novartis and Roche (less than $10,000 each) and research support from Novartis. Dr. Rieber has received consulting fees, speaking fees, and\/or honoraria from Novartis (less than $10,000 each) and research support from Novartis. Dr. Hufnagel has received research support from Novartis and Roche. Dr. Jansson has received consulting fees, speaking fees, and\/or honoraria from Novartis (less than $10,000 each) and research support from Novartis. Dr. Hedrich has received consulting fees, speaking fees, and\/or honoraria from Novartis and Roche (less than $10,000 each). Dr. Foeldvari has received consulting fees, speaking fees, and\/or honoraria from Abbvie, Bayer, Chugai, Genentech, Medac, Novartis and Pfizer (less than $10,000 each). Dr. Hospach has received consulting fees, speaking fees, and\/or honoraria from Chugai and Novartis (less than $10,000 each). Dr. Huppertz has received consulting fees, speaking fees, and\/or honoraria from Chugai, Novartis, Pfizer and Roche (less than $10,000 each). Dr. M\u00f6nkem\u00f6ller has received consulting fees, speaking fees, and\/or honoraria from Novartis (less than $10,000 each). Dr. Wei\u00dfbarth-Riedel has received consulting fees, speaking fees, and\/or honoraria from Novartis (less than $10,000 each). Dr. Wittkowski has received consulting fees, speaking fees, and\/or honoraria from Novartis (less than $10,000 each). Dr. Horneff has received honoraria from Abbvie, Novartis, Pfizer and Roche-Chugai (less than $10,000 each) and research support from Abbvie, Novartis, Pfizer and Roche-Chugai. Dr. F\u00f6ll has received honoraria from Novartis, Pfizer, Roche-Chugai and Sobi (less than $10,000 each) and research support from Novartis and Pfizer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"7"}}